ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
4.890
-0.130 (-2.59%)
At close: Sep 18, 2026, 4:00 PM EDT
4.860
-0.030 (-0.61%)
After-hours: Sep 18, 2026, 4:10 PM EDT
ImageneBio Market Cap
ImageneBio has a market cap or net worth of $55.51 million as of September 18, 2026. Its market cap has decreased by -40.55% in one year.
Market Cap
55.51M
Enterprise Value
-78.73M
1-Year Change
-40.55%
Ranking
Category
Stock Price
$4.89
ChartMarket Cap Chart
Since July 28, 2025, ImageneBio's market cap has decreased from $183.04M to $55.51M, a decrease of -69.67%. That is a compound annual growth rate of -64.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 55.51M | -28.05% |
| Dec 31, 2025 | 77.15M | -57.85% |
| Jul 28, 2025 | 183.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MiNK Therapeutics | 61.49M |
| Hyperion DeFi | 60.91M |
| Xilio Therapeutics | 59.81M |
| eXoZymes | 59.73M |
| Heron Therapeutics | 58.80M |
| Dogwood Therapeutics | 57.45M |
| Serina Therapeutics | 57.15M |
| Edesa Biotech | 55.94M |